Organogenesis Holdings Inc. (NASDAQ:ORGO) Q2 2024 Earnings Call Transcript
Operator: Please stand by. Welcome ladies and gentlemen to the Second Quarter 2024 Earnings Conference Call for Organogenesis Holdings Inc.
Organogenesis Holdings Inc. (ORGO)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Soleus Capital Guy Levy | 11,518,954 | $32,253,071 | +21% | 2.84% |
| 2. | AQR Capital Management Cliff Asness | 2,268,760 | $6,352,528 | +77% | 0% |
| 3. | Renaissance Technologies Jim Simons | 795,700 | $2,227,960 | -2% | 0% |
| 4. | D E Shaw D. E. Shaw | 741,933 | $2,077,413 | +18% | 0% |
| 5. | Two Sigma Advisors John Overdeck And David Siegel | 616,600 | $1,726,480 | -25% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.56 | 3,000 | Large Shareholder | 76,382 | 2022-11-21 | Filing | |
| $2.57 | 3,000 | Large Shareholder | 73,382 | 2022-11-18 | Filing | |
| $4.76 | 3,000 | Director | 70,854 | 2022-08-12 | Filing | |
| $4.80 | 5,000 | Director | 25,547 | 2022-08-12 | Filing | |
| $6.10 | 3,000 | Large Shareholder | 70,382 | 2022-05-16 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.28 | 17,972 | Large Shareholder | 59,007,134 | 2024-01-10 | Filing | |
| $4.37 | 197,921 | Large Shareholder | 59,025,106 | 2024-01-09 | Filing | |
| $4.28 | 17,972 | Large Shareholder | 59,007,134 | 2024-01-10 | Filing | |
| $4.37 | 197,921 | Large Shareholder | 59,025,106 | 2024-01-09 | Filing | |
| $2.07 | 25,000 | Large Shareholder | 59,223,027 | 2023-04-12 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 13,377,756 | $54,715,024 | 0% | |
| 2. | 5,360,727 | $21,925,373 | 0% | |
| 3. | 5,198,187 | $21,260,584 | 0% | |
| 4. | 2,511,426 | $10,271,732 | 0% | |
| 5. | 1,696,868 | $6,940,900 | 0% |
News See All
10 Best NASDAQ Penny Stocks To Invest In
Penny stocks are companies that are trading under $5 per share. They represent a unique and controversial segment of the financial market.
Organogenesis Holdings Inc. (NASDAQ:ORGO) Q1 2024 Earnings Call Transcript
Organogenesis Holdings Inc. beats earnings expectations. Reported EPS is $-0.02, expectations were $-0.03.
Organogenesis Holdings Inc. (NASDAQ:ORGO) Q4 2023 Earnings Call Transcript
Operator: Welcome ladies and gentlemen to the Fourth Quarter and Fiscal Year 2023 Earnings Conference Call for Organogenesis Holdings Inc.
Organogenesis Holdings Inc. (NASDAQ:ORGO) Q3 2023 Earnings Call Transcript
Operator: Welcome, ladies and gentlemen, to the Third Quarter of Fiscal Year 2023 Earnings Conference Call for Organogenesis Holdings Inc. [Operator Instructions].
12 Best Micro Cap Stocks To Invest In
In this piece, we will take a look at the 12 best micro cap stocks to invest in.
Organogenesis Holdings Inc. (NASDAQ:ORGO) Q2 2023 Earnings Call Transcript
Operator: Welcome, ladies and gentlemen, to the Second Quarter of Fiscal Year 2023 Earnings Conference Call for Organogenesis Holdings Inc. [Operator Instructions].
Organogenesis Holdings Inc. (NASDAQ:ORGO) Q1 2023 Earnings Call Transcript
Operator: Welcome, ladies and gentlemen to the First Quarter of Fiscal Year 2023 Earnings Conference Call for the Organogenesis Holdings Inc.
Organogenesis Holdings Inc. (NASDAQ:ORGO) Q4 2022 Earnings Call Transcript
Operator: Welcome, ladies and gentlemen to the Fourth Quarter and Fiscal Year 2022 Earnings Conference Call for Organogenesis Holdings Inc.
5 Most Undervalued Penny Stocks To Buy According To Hedge Funds
In this article, we will take a look at the 5 most undervalued penny stocks to buy according to hedge funds.
Billionaire Hedge Funds
